Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2026
Earnings, Q1 FY2026
May 8, 2026
Net revenue reached SEK 15,330 in Q1 2026, with ongoing digital and AI-driven transformation.
2025
Earnings, Q4 FY2025
Annual
Feb 24, 2026
Shifted to AI and digital services, reporting a net loss but securing a clean audit opinion.
Earnings, Q3 FY2025
Nov 24, 2025
Limited Q3 revenue and ongoing losses amid digital and AI-focused transformation and acquisitions.
Earnings, Q2 FY2025
Aug 20, 2025
Q2 2025 marked a strategic shift to digital and AI, with negative results driven by restructuring.
Earnings, Q1 FY2025
May 14, 2025
Medimi AB divests core business after Q1 sales growth, shifting focus to a reverse acquisition.
2024
Earnings, Q4 FY2024
Annual
Feb 12, 2025
Revenue up 32% but net loss deepens; Danish unit to be sold, Swedish operations restructured.
Earnings, Q3 FY2024
Nov 25, 2024
Q3 sales up 27% year-over-year, with Denmark driving growth and expansion capital secured.
M&A Announcement
Oct 4, 2024
Medimi to acquire MedThings, boosting Nordic digital medication management and growth.
Earnings, Q2 FY2024
Aug 21, 2024
Q2 2024 sales up 30% in Denmark, with improved results and Nordic expansion ongoing.